Hiroto Inaba, MD, PhD
St. Jude Children's Research Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hiroto Inaba, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:11 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06177067 · Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid LeukemiaSt. Jude Children's Research Hospital · recruiting · Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Acute Leukemia of Ambiguous Lineage · principal investigator
- Ph2NCT05955261 · A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid LeukemiaSt. Jude Children's Research Hospital · recruiting · Acute Myeloid Leukemia · principal investigator
- Ph2/Ph3NCT03117751 · Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and LymphomaSt. Jude Children's Research Hospital · active not recruiting · Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma · principal investigator
- Ph1NCT02270788 · Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic MalignanciesSt. Jude Children's Research Hospital · completed · Acute Myeloid Leukemia · principal investigator
- Ph2NCT01451515 · NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic LymphomaSt. Jude Children's Research Hospital · completed · Lymphoblastic Lymphoma · principal investigator
- Ph1NCT00908167 · Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic MalignanciesSt. Jude Children's Research Hospital · completed · Acute Myeloid Leukemia, Infantile Leukemia (Both AML and ALL), Myelodysplastic Syndrome · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:11 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Tyrosine kinase inhibitors for the treatment of childhood AMLR01CA138744 · NCI · OHIO STATE UNIVERSITY · PI Sharyn D Baker · fiscal years 2010 to 2019Named on NCT00908167
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in acute myeloid leukemia.